A new editorial paper was published in Oncotarget’s Volume 15 on July 2, 2024, entitled, “DDX41 and its unique contribution to myeloid leukemogenesis.”
Abivax files registration statement for proposed initial public offering in the United States – Biotech Investments
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax files registration statement for proposed initial public offering in the United States 29.09.2023 / 23:00 CET/CEST The issuer